OLD National Bancorp IN purchased a new position in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 14,500 shares of the company's stock, valued at approximately $204,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Retirement Systems of Alabama acquired a new position in Enhabit during the third quarter worth about $982,000. Landscape Capital Management L.L.C. acquired a new position in Enhabit during the third quarter worth about $220,000. Foster & Motley Inc. acquired a new position in Enhabit during the third quarter worth about $153,000. Maryland State Retirement & Pension System acquired a new position in Enhabit during the third quarter worth about $340,000. Finally, BCR Wealth Strategies LLC purchased a new position in Enhabit during the third quarter worth about $78,000. 95.55% of the stock is currently owned by institutional investors and hedge funds.
Get
Enhabit alerts:
Enhabit Trading Down 5.7 %
Shares of EHAB stock opened at $15.10 on Monday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.50 and a current ratio of 1.50. The company has a 50 day moving average price of $13.87 and a 200 day moving average price of $14.25. Enhabit, Inc. has a fifty-two week low of $11.65 and a fifty-two week high of $25.25.
Insider Activity at Enhabit
In other Enhabit news, Director Jeffrey Bolton acquired 2,000 shares of the company's stock in a transaction that occurred on Wednesday, November 9th. The stock was purchased at an average price of $12.75 per share, for a total transaction of $25,500.00. Following the completion of the acquisition, the director now owns 14,597 shares of the company's stock, valued at approximately $186,111.75. The acquisition was disclosed in a filing with the SEC, which can be accessed through
the SEC website.
Analyst Upgrades and Downgrades
EHAB has been the topic of a number of analyst reports. UBS Group initiated coverage on shares of Enhabit in a research note on Thursday, December 8th. They set a "sell" rating and a $12.00 target price on the stock. CJS Securities began coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Oppenheimer began coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. Stifel Nicolaus began coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Finally, Credit Suisse Group reduced their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $16.43.
Enhabit Company Profile
(Get Rating)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Featured Stories
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Get Rating).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
